Dose-dependent efficacy of daratumumab (DARA) as monotherapy in patients with relapsed or refractory multiple myeloma (RR MM).

被引：6
|
作者：
Lokhorst, Henk M.
Laubach, Jacob
Nahi, Hareth
Plesner, Torben
Gimsing, Peter
Hansson, Markus
Minnema, Monique
Lassen, Ulrik Niels
Krejcik, Jakub
Ahmadi, Tahamtan
Lisby, Steen
Basse, Linda
Brun, Nikolai C.
Richardson, Paul G.
机构：
[1] UMC Utrecht, Utrecht, Netherlands
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Karolinska Univ Sjukhuset Huddinge, Huddinge, Sweden
[4] Vejle Hosp, Vejle, Denmark
[5] Copenhagen Univ Hosp, Copenhagen, Denmark
[6] Skane Univ Hosp, Lund, Sweden
[7] Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark
[8] Janssen Res & Dev, Spring House, PA USA
[9] Genmab AS, Copenhagen, Denmark
[10] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.8513
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8513
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma
    Shinsuke Iida
    Tatsuo Ichinohe
    Atsushi Shinagawa
    Kenshi Suzuki
    Naoki Takezako
    Masayuki Aoki
    International Journal of Hematology, 2018, 107 : 460 - 467
  • [32] Melflufen Therapy for Relapsed Refractory Multiple Myeloma (RRMM) Patients Refractory to Daratumumab and/or Pomalidomide: A Report on Early Efficacy
    Mateos, Maria-Victoria
    Blade, Joan
    Larocca, Alessandra
    Oriol, Albert
    Rodriguez, Paula
    Alegre, Adrian
    Cavo, Michele
    Moreb, Jan S.
    Paner, Agne
    Gabrail, Nashat
    Halka, Kathleen G.
    Hassoun, Hani
    Maisel, Christopher
    Mazumder, Amitabha
    Zonder, Jeffrey A.
    Ocio, Enrique M.
    Byrne, Catriona
    Harmenberg, Johan
    Thuresson, Sara
    Nordstrom, Eva
    Lindberg, Jakob
    Richardson, Paul G.
    BLOOD, 2017, 130
  • [33] Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second
    Kim, Jin-Hyo
    Park, Sung-Soo
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Kim, Hee-Je
    Min, Chang-Ki
    BLOOD RESEARCH, 2022, 57 (01) : 76 - 80
  • [34] Daratumumab Monotherapy in Heavily Pretreated Asian Patients With Relapsed and Refractory Multiple Myeloma: A Real-world Experience
    Byun, Ja Min
    Yoon, Sung-Soo
    Koh, Youngil
    Kim, Inho
    Jo, Jaemin
    Park, Hyunkyung
    Lee, Jeong-Ok
    Lee, Jiyun
    ANTICANCER RESEARCH, 2019, 39 (09) : 5165 - 5170
  • [35] EFFECTIVENESS AND SAFETY ANALYSIS OF DARATUMUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Kumar, Seri A.
    Fe, Bitaube R.
    Hinojosa, Orantos C.
    Gavira, Moreno R.
    Garzon, Lopez S.
    HAEMATOLOGICA, 2021, 106 (10) : 339 - 340
  • [36] Daratumumab monotherapy for relapsed/refractory multiple myeloma, focussed on clinical trial-unfit patients and subsequent therapy
    Park, Sung-Soo
    Byun, Ja Min
    Yoon, Sung-Soo
    Kim, Kihyun
    Jung, Sung-Hoon
    Lee, Je-Jung
    Min, Chang-Ki
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (01) : 101 - 112
  • [37] Results of the daratumumab monotherapy early access treatment protocol in patients from Brazil with relapsed or refractory multiple myeloma
    Crusoe, Edvan de Queiroz
    Fernandes Pimenta, Flavia Cristina
    Maiolino, Angelo
    de Castro, Nelson Siqueira
    Pei, Huiling
    Trufelli, Damila
    Fernandez, Mariana
    Herriot, Luciana Barreto
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2021, 43 (04) : 417 - 423
  • [38] Subcutaneous delivery of daratumumab in Japanese patients with relapsed/refractory multiple myeloma
    Shibayama, Hirohiko
    Matsumoto, Morio
    Kosugi, Hiroshi
    Shibayama, Kazuhiro
    Yamazaki, Hiroshi
    Iida, Shinsuke
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (01) : 112 - 121
  • [39] Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma
    Chari, Ajai
    Martinez-Lopez, Joaquin
    Mateos, Maria-Victoria
    Blade, Joan
    Benboubker, Lotfi
    Oriol, Albert
    Arnulf, Bertrand
    Rodriguez-Otero, Paula
    Pineiro, Luis
    Jakubowiak, Andrzej
    de Boer, Carla
    Wang, Jianping
    Clemens, Pamela L.
    Ukropec, Jon
    Schecter, Jordan
    Lonial, Sagar
    Moreau, Philippe
    BLOOD, 2019, 134 (05) : 421 - 431
  • [40] Subcutaneous delivery of daratumumab in Japanese patients with relapsed/refractory multiple myeloma
    Hirohiko Shibayama
    Morio Matsumoto
    Hiroshi Kosugi
    Kazuhiro Shibayama
    Hiroshi Yamazaki
    Shinsuke Iida
    International Journal of Hematology, 2021, 113 : 112 - 121
12345